NanoVibronix Forges Agreement to Distribute PainShield and WoundShield in Israel

NanoVibronix Inc., a medical device company utilizing the company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, has entered into an exclusive agreement with M.D.S. Pharm Ltd. to market and distribute NanoVibronix’s PainShield and WoundShield in Israel.
 
M.D.S. Pharm Ltd. is a distributor of medical equipment for home-care and self-diagnostics. An integral element of the company’s mission is to provide customers with alternatives to medication and/or pain relief drugs. M.D.S. has an established distribution network in Israel that includes health insurance providers, private pharmacies, health stores, beautician centers, private clinics, and health websites.
 
Dorit Grinberg, CEO of MDS Pharm Ltd., stated, “We are excited to partner with NanoVibronix to market and distribute PainShield and WoundShield in Israel. There is a growing body of clinical evidence that demonstrates the products’ ability to treat pain and induce soft tissue healing in targeted areas, in many cases as an alternative to opioids and other pain medications.”
 
PainShield and WoundShield are ultrasound devices each consisting of a reusable driver unit and a disposable patch, which contains a proprietary therapeutic transducer. PainShield and WoundShield deliver a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area, while keeping the level of ultrasound energy at a safe and consistent level. Its range of applications includes acute and chronic pain resolution through its many mechanisms of action. PainShield, which has broad applications for sports injuries, has been acknowledged by several sports icons. Both PainShield and WoundShield can be used by patients at home or work or in a clinical setting and can be used even while the patient is sleeping. Patient benefits noted in our clinical studies include ease of application and use, faster recovery time, high compliance, and mechanisms of action that affect soft tissue repair.
 
Brian Murphy, CEO of NanoVibronix, commented, “We are excited to partner with M.D.S. in Israel, as they bring a distribution network that spans a variety of sales channels, ranging from insurance and health care providers to retail pharmacies and stores, as well as a variety of online distribution points.”
 
NanoVibronix Inc. is a medical device company headquartered in Elmsford, N.Y., with research and development in Nesher, Israel, that is focused on developing products utilizing its proprietary and patented low intensity surface acoustic wave technology. The company’s technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including the disruption of biofilms and bacteria colonization, as well as providing pain relief. The devices can be administered at home without the assistance of medical professionals. The company’s primary products include PainShield, UroShield, and WoundShield.